ask="1.35"
ask_size="4500"
average_daily_volume="942648"
bid="1.30"
bid_size="4900"
book_value="1.06"
change="-0.10"
change_from_200_day_moving_average="-1.12"
change_from_50_day_moving_average="0.00"
change_from_52_week_high="-7.60"
change_From_52_week_low="0.36"
change_in_percent="-7.14%"
close="1.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.55"
ebitda="-79.23M"
eps_estimate_current_year="-1.34"
eps_estimate_next_quarter="-0.35"
eps_estimate_next_year="-1.62"
ex_dividend_date="N/A"
float_shares="36689000"
high="1.40"
high_52_weeks="8.90"
last_trade_date="3/15/2017"
last_trade_price="1.30"
last_trade_size="17888"
last_trade_time="4:00pm"
low="1.30"
low_52_weeks="0.94"
market_capitalization="68.81M"
moving_average_200_day="2.42"
moving_average_50_day="1.30"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="22.67"
open="1.40"
pe_ratio="N/A"
peg_ratio="-0.03"
percent_change_from_200_day_moving_average="-46.32%"
percent_change_from_50_day_moving_average="+0.26%"
percent_change_from_52_week_high="-85.39%"
percent_change_from_52_week_low="+38.30%"
previous_close="1.40"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.32"
price_per_sales="62.06"
revenue="1.19M"
shares_outstanding="52932000"
short_ratio="2.27"
stock_exchange="NGM"
symbol="RGLS"
volume="1057269"
weeks_range_52="0.94 - 8.90"
